Incannex Healthcare Ltd (ASX: IHL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Incannex Healthcare Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$645.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Shares Outstanding
1.28 billion
Earnings per share
-0.010
Dividend per share
N/A
Year To Date Return
-27.20%
Earnings Yield
N/A
Franking
N/A
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Incannex Healthcare Ltd (ASX: IHL)
Latest News
Healthcare Shares
Incannex share price pops 9% on FDA news
Share Gainers
Why CBA, Incannex, Judo Capital, and Orica shares are rising
Cannabis Shares
Here’s why the Incannex share price is rocketing 18% today
Healthcare Shares
Down 25% in a month, the Incannex share price is now halted. Here’s why
Cannabis Shares
How have ASX cannabis shares been performing so far in 2022?
Mergers & Acquisitions
Incannex (ASX:IHL) share price slips on acquisition news
Healthcare Shares
Here’s why the Incannex (ASX:IHL) share price is on ice today
Share Gainers
The Incannex (ASX:IHX) share price is up a whopping 50% in a week. What’s the deal?
IHL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Incannex Healthcare Ltd
Formerly Mount Magnet South Limited (MUM), 28/10/2016; Impression Healthcare Limited (IHL), 03/07/2020.
IHL Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 17 May 2022 | $0.51 | $0.05 | 10.99% | 6,819,968 | $0.47 | $0.51 | $0.47 |
| 16 May 2022 | $0.46 | $-0.01 | -2.17% | 3,358,630 | $0.46 | $0.48 | $0.45 |
| 13 May 2022 | $0.46 | $0.06 | 15.00% | 6,764,765 | $0.41 | $0.46 | $0.40 |
| 12 May 2022 | $0.40 | $0.04 | 10.96% | 7,428,482 | $0.37 | $0.44 | $0.36 |
| 11 May 2022 | $0.37 | $-0.01 | -2.70% | 2,296,458 | $0.38 | $0.38 | $0.36 |
| 10 May 2022 | $0.37 | $-0.01 | -2.63% | 8,626,793 | $0.37 | $0.38 | $0.33 |
| 05 May 2022 | $0.38 | $0.05 | 14.93% | 5,830,773 | $0.35 | $0.40 | $0.34 |
| 04 May 2022 | $0.34 | $-0.05 | -13.16% | 9,549,894 | $0.39 | $0.39 | $0.34 |
| 03 May 2022 | $0.38 | $-0.01 | -2.56% | 3,447,982 | $0.40 | $0.41 | $0.38 |
| 02 May 2022 | $0.39 | $-0.02 | -4.94% | 3,503,810 | $0.41 | $0.41 | $0.39 |
| 29 Apr 2022 | $0.41 | $0.01 | 2.50% | 2,120,889 | $0.41 | $0.43 | $0.40 |
| 28 Apr 2022 | $0.40 | $0.01 | 2.53% | 3,043,936 | $0.41 | $0.44 | $0.40 |
| 27 Apr 2022 | $0.40 | $-0.01 | -2.50% | 3,097,308 | $0.40 | $0.43 | $0.39 |
| 26 Apr 2022 | $0.40 | $-0.03 | -7.06% | 4,609,128 | $0.41 | $0.42 | $0.40 |
| 22 Apr 2022 | $0.43 | $-0.01 | -2.30% | 3,059,752 | $0.43 | $0.44 | $0.42 |
| 21 Apr 2022 | $0.44 | $-0.02 | -4.40% | 2,364,426 | $0.46 | $0.46 | $0.44 |
| 20 Apr 2022 | $0.46 | $-0.01 | -2.15% | 3,845,519 | $0.47 | $0.48 | $0.45 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 06 Oct 2021 | Sudhanshu Agarwal | Exercise | 20 | $4,199,900 |
Exercise of options. As per announcement on 07/10/2021
|
| 06 Oct 2021 | Sudhanshu Agarwal | Buy | 20 | $4,199,900 |
Exercise of options.
|
| 21 Sep 2021 | Troy Valentine | Buy | 7 | $569,356 |
Exercise of options.
|
| 21 Sep 2021 | Troy Valentine | Exercise | 7 | $569,356 |
Exercise of options.
|
| 21 Sep 2021 | Peter Widdows | Exercise | 657 | $52,631 |
Exercise of options.
|
| 21 Sep 2021 | Peter Widdows | Buy | 657 | $52,631 |
Exercise of options.
|
| 06 Sep 2021 | Joel Latham | Exercise | 200 | $16,000 |
Exercise of options.
|
| 06 Sep 2021 | Joel Latham | Buy | 200 | $16,000 |
Exercise of options.
|
| 06 Sep 2021 | Sudhanshu Agarwal | Buy | 20 | $4,000,000 |
Exercise of options.
|
| 06 Sep 2021 | Sudhanshu Agarwal | Exercise | 20 | $4,000,000 |
Exercise of options.
|
| 30 Jun 2021 | Sudhanshu Agarwal | Expiry | 2 | $500,000 |
As advised by the company. Lapse of performance rights
|
| 30 Jun 2021 | Joel Latham | Expiry | 5 | $1,250,000 |
As advised by the company. As per announcement on 01/07/2021.
Lapse of performance rights |
| 30 Jun 2021 | Peter Widdows | Expiry | 1 | $375,000 |
As advised by the company. As per announcement on 01/07/2021
Lapse of performance rights |
| 30 Jun 2021 | Troy Valentine | Expiry | 1 | $375,000 |
As advised by the company. Lapse of performance rights
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Troy Robert Valentine | Non-Executive ChairmanNon-Executive Director | Dec 2017 |
Mr Valentine is a finance professional with managerial and Board experience spanning over 27 years. He commenced his career with Australian brokerage firm Hartley Poynton (now Euroz Hartley's Limited) in 1994 before moving to Patersons Securities (now Canaccord Genuity) in 2000 and subsequently became an Associate Director. During his time at Patersons, he was responsible for managing both retail and institutional accounts. Mr Valentine has corporate and capital raising experience, with start-ups and small to mid-cap size companies. He is currently a director of Australian boutique corporate advisory firm Alignment Capital Pty Ltd, which he co-founded in 2014.
|
| Mr Peter Widdows | Non-Executive Director | Mar 2018 |
Mr Widdows has experience in Australian and international consumer goods markets and has worked as a senior executive/CEO in numerous geographies, including Europe, the USA and Asia/Pacific. He is the former Regional CEO of the H.J. Heinz corporation, with responsibility for a large portion of Asia and Australasia. He is the current Non-executive Chair of Sunny Queen Australia Ltd and a Non-Executive Director of Youi Holdings Ltd - A general insurance company.
|
| Mr Joel Bradley Latham | Chief Executive OfficerExecutive DirectorManaging Director | Jul 2018 |
Mr Latham has over 14 years of experience, with firms such as Mars Foods, Tabcorp and Philip Morris International in management and commercial operational roles. He was involved in the marketing and procurement of multiple revenue-generating opportunities and partnerships, including with Pacific Smiles (ASX:PSQ), 1300 Smiles (ASX: ONT), the National Rugby League, the Australian Football League, ONE Fighting Championship, FIT Technologies and Cannvalate.
|
| Mr Sudhanshu Agarwal | Non-Executive Director | Jul 2019 |
Dr Agarwal has been our Chief Medical Officer of Incannex since June 2019. Dr Sud Agarwal is a opinion leader in the clinical use of medicinal cannabis and is regularly invited to industry and pharmaceutical events, including the World Cannabis Conference (June 2019), the Australian Medicinal Cannabis Conference (March 2019), Prohibition Partners (September 2020) and the forthcoming International Cannabinoid Derived Pharmaceuticals Summit in Boston (September 2021). Since 2018, Dr Agarwal also serves as Chief Executive Officer and Chairman of Cannvalate, an Australian private medicinal cannabis company that owns a 3% beneficial interest in Incannex.
|
| Mr Madhukar (Madhu) Bhalla | Company Secretary | Jul 2021 |
-
|
| Madhukar (Madhu) Bhalla | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Mr Raymond Laurence Carroll | 45,250,000 | 4.20% |
| Dr Sudhanshu Agarwal | 34,303,593 | 3.18% |
| Cannvalate Pty Ltd | 32,000,000 | 2.97% |
| Mr Anthony Michael Malyniak <Ejm A/C> | 25,650,000 | 2.38% |
| Bagbo Pty Ltd | 16,556,198 | 1.54% |
| Mr Brian Peter Byass | 15,800,000 | 1.47% |
| Mr Peter Widdows | 15,315,799 | 1.42% |
| Slade Technologies Pty Ltd <Embrey Family S/F A/C> | 15,100,000 | 1.40% |
| Mr Joel Bradley Latham | 13,829,129 | 1.28% |
| Alignment Capital Pty Ltd | 13,194,248 | 1.22% |
| Cipater Pty Ltd | 12,765,000 | 1.18% |
| Mr Kaide Wang | 11,601,607 | 1.08% |
| Japl Nominees Pty Ltd <Japl Investment A/C> | 10,014,370 | 0.93% |
| Ellaz Pty Ltd <The Ripper Family A/C> | 10,000,000 | 0.93% |
| Citicorp Nominees Pty Limited | 9,686,241 | 0.90% |
| Mr Peter Francis Scanlan | 9,500,000 | 0.88% |
| Mr Sam Boake | 9,001,493 | 0.84% |
| VBS Exchange Pty Ltd | 9,000,000 | 0.83% |
| Pelrus Pty Ltd | 7,530,000 | 0.70% |
| Ms Niomie Esther Varady | 7,185,508 | 0.67% |